Cboe Global Markets, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Cboe Global Markets, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.23B | Feb 22, 2018 |
| FY2016 | Dec 31, 2016 | $175.08M | Feb 21, 2017 |
| FY2016 | Sep 30, 2016 | $156.21M | Feb 21, 2017 |
| FY2016 | Jun 30, 2016 | $163.33M | Feb 21, 2017 |
| FY2016 | Mar 31, 2016 | $162.33M | Feb 21, 2017 |
| FY2016 | Dec 31, 2015 | $155.95M | Feb 21, 2017 |
| FY2016 | Sep 30, 2015 | $187.04M | Feb 21, 2017 |
| FY2016 | Jun 30, 2015 | $148.73M | Feb 21, 2017 |
| FY2016 | Mar 31, 2015 | $142.84M | Feb 21, 2017 |
| FY2015 | Dec 31, 2014 | $166.49M | Feb 19, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $764.90M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $761.40M | Feb 20, 2026 |
| FY2021 | Dec 31, 2021 | $529.00M | Feb 18, 2022 |
| FY2021 | Dec 31, 2020 | $468.20M | Feb 18, 2022 |
| FY2021 | Dec 31, 2019 | $374.90M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $426.50M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $401.70M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $186.80M | Feb 22, 2019 |
| FY2017 | Dec 31, 2015 | $205.00M | Feb 22, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.10B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.06B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $489.60M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $805.90M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $134.80M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $139.30M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $161.70M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $226.40M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $119.20M | Feb 19, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.31B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $7.79B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $7.49B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $7.00B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $6.81B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $6.52B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $5.11B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $5.32B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $5.27B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $476.70M | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.17B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $3.51B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.50B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.53B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.21B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.17B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.76B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.07B | Feb 21, 2020 |
| FY2016 | Dec 31, 2016 | $146.07M | Feb 21, 2017 |
| FY2016 | Dec 31, 2015 | $125.14M | Feb 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.14B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $4.28B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $3.99B | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $3.47B | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $3.60B | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $3.35B | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | $3.36B | Feb 17, 2023 |
| FY2021 | Dec 31, 2018 | $3.24B | Feb 18, 2022 |
| FY2020 | Dec 31, 2017 | $3.11B | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $317.90M | Feb 21, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.22B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $920.30M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $543.20M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $432.70M | Feb 16, 2024 |
| FY2023 | Dec 31, 2021 | $341.90M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $245.40M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $229.30M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $275.10M | Feb 19, 2021 |
| FY2018 | Dec 31, 2017 | $143.50M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $97.30M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.44B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.44B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.74B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.30B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.20B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $867.60M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.22B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.24B | Feb 22, 2019 |